Marshall Wace’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-25,122	Closed	-$2.63M	–	1183
2014 Q2	$2.63M	Buy	+25,122	New	+$2.63M	0.04%	353